September is addiction recovery month, and, in the midst of
FDA Issues Statement Reaffirming the Positive Benefit-Risk Profile of Nuplazid (pimavanserin) for Patients with Hallucinations and Delusions Associated with Parkinson’s Disease Psychosis
SAN DIEGO–(BUSINESS WIRE)–Sep. 20, 2018– Acadia Pharmaceuticals Inc. (NASDAQ: ACAD)
Hasbinding do exercises for the face to preserve youth?
Is the face fitness gives a very enticing promises: they
Researchers deploy novel clinical trial regimen for glioblastoma
Combating glioblastoma remains a major challenge due the complex nature
API expands health data into risk scores, but are consumers ready for it?
Source: Read Full Article
Alcohol responsible for one in 20 deaths worldwide: WHO
Alcohol kills three million people worldwide each year—more than AIDS,
Self-satisfaction: Why they talk especially with your Partner openly about it should
Over Masturbation is spoken quite open – men make jokes
The 180-degree turn: FSIN allows for the possibility of substitution therapy for drug addicts
Absolutely unbelievable in the present context the statement was voiced
Heart Defects, Sleep Apnea a Deadly Mix for Infants
THURSDAY, Sept. 20, 2018 — Infants who are born with
Cardiac monitoring needed for high-risk breast cancer patients
(HealthDay)—Risk of cardiotoxicity is higher for patients receiving trastuzumab and/or